Perfusion density and vessel density of SCP were already reduced at baseline in type 2 diabetes (expected difference compared with control participants: −0.0071, p=0.0276, expected difference: −0.0034, p=0.0184, respectively), especially in participants with severe insulin-deficient and mild obesity-related diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.